Dermata Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$7,794,690 over the previous period. Total operating expenses were $8,041,906.
Profit Margin
| 2019 | 0 | -4.97M | |
|---|---|---|---|
| 2020 | 0 | -3.43M | |
| 2021 | 0 | -7.94M | |
| 2022 | 0 | -9.61M | |
| 2023 | 0 | -7.79M |
DRMA Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 322 | 1.35K |
Gross profit | 0 | 0 | 0 | -322 | -1.35K |
Operating exp. | |||||
Research and development | 4.06M | 5.65M | 3.45M | 1.60M | 2.62M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 8.04M | 9.67M | 7.85M | 3.17M | 4.47M |
Operating income | -8.04M | -9.67M | -7.85M | -3.17M | -4.47M |
Other income (expenses), net | 247.21K | 63.57K | -45.61K | -63.67K | -250.74K |
Income before tax | -7.79M | -9.61M | -7.90M | -3.23M | -4.72M |
Income tax expense | 0 | -9.67K | 45.61K | 197.26K | 250.74K |
Net income | -7.79M | -9.61M | -7.94M | -3.43M | -4.97M |
Earnings per share | |||||
Basic EPS | -40.18 | -13.92 | -15.27 | -6.6 | -9.55 |
Diluted EPS | -39.98 | -13.92 | -15.27 | -6.6 | -9.55 |
| Data source | Data source | Data source |